Use of the “Triple Test” for palpable breast lesions yields high diagnostic accuracy and cost savings

1995 ◽  
Vol 169 (5) ◽  
pp. 519-522 ◽  
Author(s):  
John Vetto ◽  
Rodney Pommier ◽  
Waldemar Schmidt ◽  
Mitchell Wachtel ◽  
Polly DuBois ◽  
...  
1984 ◽  
Vol 25 (4) ◽  
pp. 273-276 ◽  
Author(s):  
M. Kehler ◽  
U. Albrechtsson

Results with a previously described device for fine needle biopsies of non-palpable breast lesions are reported. During the past 5 years 182 biopsies were performed and 133 of these yielded diagnostic cell material. In the series, 41 carcinomas were found and fine needle biopsy in all demonstrated malignant or probably malignant cells. In the biopsies evaluated as benign or probably benign, malignancy has not been found during the observation period of 4 to 59 months (mean 21.5 months). The device described is cheap and biopsy is easily performed and, if necessary, repeated in a short time. The diagnostic accuracy is high and carcinomas as small as 3 mm in diameter have been diagnosed.


1999 ◽  
Vol 43 (3) ◽  
pp. 339-343 ◽  
Author(s):  
Naghmeh Salami ◽  
Sharon L. Hirschowitz ◽  
Roberta K. Nieberg ◽  
Sophia K. Apple

1994 ◽  
Vol 190 (1) ◽  
pp. 69-76 ◽  
Author(s):  
S. Bianchi ◽  
D. Palli ◽  
M. Galli ◽  
B. Arisio ◽  
A. Cappal ◽  
...  

2020 ◽  
Vol 5 (3) ◽  
pp. 1196-1200
Author(s):  
Manish Raj Pathak ◽  
Mahesh Gautam ◽  
Rashmita Bhandari

Introduction: Breast carcinoma is the second leading cause of cancer related mortality in females around the world. Ultrasound plays a key role in differentiating cystic and solid lesions and is a convenient and non-invasive diagnostic tool to differentiate between benign and malignant lesions. Objectives: The aim of this study is to evaluate the diagnostic accuracy of ultrasound in palpable breast lesions. Methodology: A prospective cross-sectional study was carried out in patients with palpable breast lesions who presented in Department of radio diagnosis and imaging of Nobel Medical collegefor a period of one-year from February 2019- January 2020 using ultrasound. A total of 60 patientswereevaluated in the study. Sensitivity, specificity, positive predictive value, negative predictive value and accuracy were calculated. Results: Out of 60 patients evaluated, ultrasound showed 46 (76.7%) cases to be benign and 14 (23.3%) cases to be malignant. FNAC revealed benign disease in 47 (78.3%) patients and malignant disease in 13 (21.7%) patients. The most common benign lesion was fibroadenoma. We found nearly 91.7% of the malignant lesions had spiculated margins and microcalcification. The sensitivity of ultrasound was 95.74% and specificity 92.3% with diagnostic accuracy 95%. Conclusion: Ultrasound is a convenient and non-invasive diagnostic tool with good sensitivity, specificity, positive predictive value, negative predictive value and accuracy in palpable breast lesions.


1997 ◽  
Vol 24 (2) ◽  
pp. 120-123 ◽  
Author(s):  
Ruud M. Pijnappel ◽  
Albert van Dalen ◽  
Inne H.M. Borel Rinkes ◽  
Jan G. van den Tweel ◽  
Willem P.Th.M. Mali

2021 ◽  
Vol 8 (8) ◽  
pp. 2350
Author(s):  
Radha K. ◽  
Uma M.

Background: Breast (mammary gland) is a distinguishing feature of class Mammalia. Patients commonly present, complaining of a lump in the breast, pain, and nipple discharge. Although the most common cause of symptoms is benign breast diseases. But as the life expectancy is increasing incidence of carcinoma breast is also increasing. 1.To assess the individual component diagnostic accuracy of MTT.Methods: This was a cross-sectional study involving 50 female patients with palpable breast lumps attending the Surgical Out-Patient of the Department of General Surgery, Government Royapettah Hospital, Kilpauk medical college, Chennai between June 2020 and May 2021 over 12 months, who underwent clinical breast examination (CBE), ultrasonography (USG), and fine-needle aspiration cytology (FNAC). Results: In the study population, the breast tumor is common on the left side account for about overall 53%age of patients. The bilateral tumors are the least common. Fibroadenoma is the most common benign tumor. In our study also similar results were obtained. The next common benign tumor among the study group is a fibrocystic disease of the breast. Analysis of the above results shows that though FNAC has a sensitivity of 90%, it has a positive predictive value of 100%. The study shows that the combined results of the Modified Triple Test are comparable to the histopathological diagnosis of the biopsy specimen. Conclusions: Our study includes assessment of combined diagnostic accuracy of Modified Triple Test in women of more than 30 years of age with a palpable breast lump.


2020 ◽  
pp. 1-3
Author(s):  
Sitesh Kumar Karn ◽  
Ramesh Kumar Ajai ◽  
Debarshi Jana

Background:Breast diseases constitute a heterogeneous group of lesions including developmental abnormalities,inflammatory lesions, epithelial and stromal proliferations, and neoplasms. With the use of clinical examination, mammography and fine needle aspiration cytology (FNAC), the diagnosis of a benign breast disease can be accomplished without surgery in the majority of patients. Combined use of these diagnostic procedures (Triple assessment) gives nearly the same degree of accuracy as excisional biopsy in patients with palpable breast diseases. Currently a combination of three tests, i.e. clinical examination, radiological imaging (mammography, ultrasonography) and pathology called as triple assessment test is used to accurately diagnose all palpable breast lumps. The Triple Test Score (TTS) was developed to help physicians interpret discordant triple test results. A three-point scale is used to score each component of the triple test (1 = benign, 2 = suspicious, 3 = malignant). A TTS of 3 or 4 is consistent with a benign lesion; a TTS of 6 or more indicates possible malignancy that may require surgical intervention. Excisional biopsy is recommended in patients with a TTS of 5 to obtain a definitive diagnosis. Materials and methods: The study was conducted for diagnostic accuracy of triple assessment in palpable breastlump in 50 patients. The components of the Triple Assessment are: Clinical examination (C/E), Mammography/ ultrasonograph and Fine Needle Aspiration Cytology (FNAC). The diagnostic accuracy of triple asseserment was reached by comparing the results of this test with gold standard i.e. histopathological findings. Results :The TT was concordant in 46 cases (92%). In 17 of these lesions (34%), the results of TT were interpretedas benign and subsequently were proved to be benign pathologies histologically with NPV and Specificity of 100٪.Similarly, in 29 cases (58٪) the results of all elements of TT were interpreted as malignant, which proved to be malignant lesions on histopathological examination and the sensitivity and PPV were 100 ٪ .TT elements were non concordant in 4 cases (8٪), 3 of these cases were proved to have malignant masses and the remaining 1 case was proved to be benign on subsequent histopathological examination. In all the non concordant cases, where at least one of the elements was considered benign, FNAC was the most accurate with 0 false negative and 0 false positive results. Conclusion: The TT has proved to be accurate, reliable diagnostic approach for evaluation of breast masses, achieved(100%) accuracy rate when all elements were concordant or when all elements were either suspicious or malignant. The study shows that when TT is concordant, final treatment may be ensued without open biopsy. In non-concordantcases, FNAC stands as single most important investigation. However due to its false negative results, other components of triple test need to be employed to enhance its efficacy and diagnostic yield.


Sign in / Sign up

Export Citation Format

Share Document